Literature DB >> 8403228

Studies of chemopreventive effects of myo-inositol on benzo[a]pyrene-induced neoplasia of the lung and forestomach of female A/J mice.

R D Estensen1, L W Wattenberg.   

Abstract

There is a continuing effort at identifying chemopreventive agents that might be useful in preventing cancer of the lung. In the present study, the effects of myo-inositol and dexamethasone on benzo[a]pyrene (B[a]P)-induced pulmonary adenoma formation in female A/J mice was investigated. A diet containing 3% myo-inositol fed beginning 1 week after B[a]P administration reduced the number of pulmonary adenomas by 40% but did not prevent forestomach tumors, which also occur in this experimental model. Under the same conditions, dexamethasone, 0.5 micrograms/g diet, inhibited pulmonary adenoma formation by 57% and also inhibited forestomach tumor formation to a similar extent. Feeding a diet containing both myo-inositol and dexamethasone resulted in an additive effect on the inhibition of pulmonary adenoma formation. The combination of myo-inositol plus dexamethasone produced almost identical inhibition of forestomach tumor formation to that of dexamethasone alone. The results of the present study are preliminary, but may provide a basis for future investigation into strategies for chemoprevention of pulmonary neoplasia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8403228     DOI: 10.1093/carcin/14.9.1975

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  16 in total

1.  Chemoprevention of mouse lung and colon tumors by suberoylanilide hydroxamic acid and atorvastatin.

Authors:  Michael A Pereira; Blake M Warner; Thomas J Knobloch; Christopher M Weghorst; Ronald A Lubet; Vernon E Steele; Bruce C Casto
Journal:  Int J Cancer       Date:  2012-01-31       Impact factor: 7.396

2.  Reduced IL-6 levels and tumor-associated phospho-STAT3 are associated with reduced tumor development in a mouse model of lung cancer chemoprevention with myo-inositol.

Authors:  Nese Unver; Oliver Delgado; Kirubel Zeleke; Amber Cumpian; Ximing Tang; Mauricio S Caetano; Hong Wang; Hiroyuki Katayama; Hua Yu; Eva Szabo; Ignacio I Wistuba; Seyed Javad Moghaddam; Samir M Hanash; Edwin J Ostrin
Journal:  Int J Cancer       Date:  2017-12-23       Impact factor: 7.396

3.  The tobacco carcinogen nitrosamine induces a differential gene expression response in tumour susceptible A/J and resistant C3H mouse lungs.

Authors:  William Gordon; Valentin Galitovskiy; Robert Edwards; Bogi Andersen; Sergei A Grando
Journal:  Eur J Cancer       Date:  2012-09-23       Impact factor: 9.162

4.  Inhibition of lung carcinogenesis and critical cancer-related signaling pathways by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-l-cysteine, indole-3-carbinol and myo-inositol, alone and in combination.

Authors:  Fekadu Kassie; Tamene Melkamu; Abaineh Endalew; Pramod Upadhyaya; Xianghua Luo; Stephen S Hecht
Journal:  Carcinogenesis       Date:  2010-07-05       Impact factor: 4.944

5.  Apoptotic effect of IP(6) was not enhanced by co-treatment with myo-inositol in prostate carcinoma PC3 cells.

Authors:  Hyun-Jung Kim; Yu-Mi Jang; Harriet Kim; Young Hye Kwon
Journal:  Nutr Res Pract       Date:  2007-09-30       Impact factor: 1.926

6.  Inhibition of vinyl carbamate-induced pulmonary adenocarcinoma by indole-3-carbinol and myo-inositol in A/J mice.

Authors:  Fekadu Kassie; Stephen Kalscheuer; Ilze Matise; Linan Ma; Tamene Melkamu; Pramod Upadhyaya; Stephen S Hecht
Journal:  Carcinogenesis       Date:  2009-07-22       Impact factor: 4.944

7.  A Randomized Phase IIb Trial of myo-Inositol in Smokers with Bronchial Dysplasia.

Authors:  Stephen Lam; Sumithra J Mandrekar; Yaron Gesthalter; Katie L Allen Ziegler; Drew K Seisler; David E Midthun; Jenny T Mao; Marie Christine Aubry; Annette McWilliams; Don D Sin; Tawimas Shaipanich; Gang Liu; Evan Johnson; Andrea Bild; Marc E Lenburg; Diana N Ionescu; John Mayo; Joanne Eunhee Yi; Henry Tazelaar; William S Harmsen; Judith Smith; Avrum E Spira; Jennifer Beane; Paul J Limburg; Eva Szabo
Journal:  Cancer Prev Res (Phila)       Date:  2016-09-22

8.  Combinations of N-Acetyl-S-(N-2-Phenethylthiocarbamoyl)-L-Cysteine and myo-inositol inhibit tobacco carcinogen-induced lung adenocarcinoma in mice.

Authors:  Fekadu Kassie; Ilze Matise; Mesfin Negia; David Lahti; Yunqian Pan; Robyn Scherber; Pramod Upadhyaya; Stephen S Hecht
Journal:  Cancer Prev Res (Phila)       Date:  2008-09

Review 9.  Chemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Eva Szabo; Jenny T Mao; Stephen Lam; Mary E Reid; Robert L Keith
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

Review 10.  Chemoprevention of lung carcinogenesis in addicted smokers and ex-smokers.

Authors:  Stephen S Hecht; Fekadu Kassie; Dorothy K Hatsukami
Journal:  Nat Rev Cancer       Date:  2009-07       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.